Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis-a cross-sectional multicenter study.Open Access

Meyer T; Salkic E; Grehl T; Weyen U; Kettemann D; Weydt P; Günther R; Lingor P; Koch JC; Petri S; Hermann A; Prudlo J; Großkreutz J; Baum P; Boentert M; Norden J; Metelmann M; Weishaupt JH; Cordts I; Ludolph A; Dorst J; Walter B; Koc Y; Spittel S; Münch C; Maier A; Dreger M; Körtvélyessy P

Research article (journal) | Peer reviewed

Abstract

The finding of moderate sNfL elevation in patients with long ALS duration underlined the favorable prognosis of low sNfL. The strong correlation of sNfL Z score with ALS-PR strengthened its value as progression marker in clinical management and research. The lowering of sNfL in correlation with long TIV duration could reflect a reduction either in disease activity or in the neuroaxonal substrate of biomarker formation during the protracted course of ALS.; The objective was to assess the performance of serum neurofilament light chain (sNfL) in amyotrophic lateral sclerosis (ALS) in a wide range of disease courses, in terms of progression, duration and tracheostomy invasive ventilation (TIV).; In the total ALS cohort (n = 1378) the sNfL Z score was elevated (3.04; 2.46-3.43; 99.88th percentile). There was a strong correlation of sNfL Z score with ALS-PR (p < 0.001). In patients with long (5-10 years, n = 167) or very long ALS duration (>10 years, n = 94) the sNfL Z score was significantly lower compared to the typical ALS duration of <5 years (n = 1059) (p < 0.001). Furthermore, in patients with TIV, decreasing sNfL Z scores were found in correlation with TIV duration and ALS-PR (p = 0.002; p < 0.001).; A prospective cross-sectional study at 12 ALS centers in Germany was performed. sNfL concentrations were age adjusted using sNfL Z scores expressing the number of standard deviations from the mean of a control reference database and correlated to ALS duration and ALS progression rate (ALS-PR), defined by the decline of the ALS Functional Rating Scale. - CONCLUSIONS - BACKGROUND AND PURPOSE - RESULTS - METHODS

Details about the publication

JournalEuropean Journal of Neurology (Eur J Neurol)
Volume30
Issue6
Page range1600-1610
StatusPublished
Release year2023 (10/03/2023)
Language in which the publication is writtenEnglish
DOI10.1111/ene.15773
Link to the full texthttps://onlinelibrary.wiley.com/doi/10.1111/ene.15773
Keywordsamyotrophic lateral sclerosis (ALS); long disease duration; sNfL Z score; serum neurofilament light chain (sNfL); tracheostomy invasive ventilation (TIV).

Authors from the University of Münster

Boentert, Matthias
Department for Neurology